Global COPD and Asthma Devices Market

Global COPD and Asthma Devices Market Size, Share, Growth Analysis, By Product Type(Chronic Obstructive Pulmonary Disease (COPD) and Asthma), By Indication(Retail Pharmacies, Hospitals and Online Pharmacies) - Industry Forecast 2023-2030


Report ID: SQMIG35B2075 | Region: Global | Published Date: February, 2024 | Pages: 157 | Tables: 60 | Figures: 69

Global COPD and Asthma Devices Market Insights

COPD and Asthma Devices Market was valued at USD 38.4 billion in 2021 and it is expected to grow from 40.28 in 2022, to USD 59.06 billion by 2030, at a CAGR of 4.9% during the forecast period (2023-2030).

Chronic obstructive pulmonary disease (COPD) is an inflammatory illness that prevents airflow from the lungs. Shortness of breath, wheezing, chest tightness, a persistent cough that produces mucus or not, recurrent colds, and sore throats are some of its early signs. On the other hand, asthma, usually referred to as bronchial asthma, is a respiratory condition that damages the lungs' airways. Breathlessness, heaviness in the chest, difficulty sleeping, and episodes of coughing or wheezing are some of its symptoms. Different devices that aid in the delivery of inhaled medicine are used to treat certain respiratory disorders. Devices for COPD and asthma, also known as pulmonary medication delivery devices, are used to treat respiratory disorders permanently or as a last resort. Devices for chronic obstructive pulmonary disease (COPD) and asthma help in medication delivery by turning drug suspensions or solutions into aerosolized particles. They are getting greatly popular worldwide. An increase in the prevalence of asthma and COPD, as well as technological developments and a rising elderly population, are the main drivers of market expansion. The demand for these devices has grown as a result of the significant rise in asthma prevalence and incidence, which has expanded the patient population.

US COPD and Asthma Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

To get more reports on the above market click here to Buy The Report

Global COPD and Asthma Devices Market Segmental Analysis

Global COPD and Asthma Devices Market is segmented based on the product type, indication, distribution channel, and region. Based on product type, global COPD and Asthma Devices Market is bifurcated into Inhalers and Nebulizers. According to indication, COPD and Asthma Devices Market is segmented into Asthma and Chronic Obstructive Pulmonary Disease (COPD). According to distribution channel, COPD and Asthma Devices Market is categorized into Retail Pharmacies, Hospitals and Online Pharmacies. Based on Region, COPD and Asthma Devices Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

COPD and Asthma Devices Market Analysis by Product Type

The market is divided into inhalers and nebulizers based on the type of device. Furthermore, the inhalers segment consists of soft mist inhalers, metered dose inhalers, and dry powder inhalers (DPIs) (SMIs). However, the nebulizers segment also includes compressor nebulizers; nebulizers that use ultrasound, and nebulizers that use mesh. The inhalers segment held largest market share in 2021 especially the dry powder inhalers segment. This can be attributed to its effectiveness in treating ailments including COPD, bronchitis, and asthma. DPI, which releases a dry pharmaceutical powder rather of a liquid mist, is anticipated to have a sizable market share in 2021. Also, when treating COPD and asthma, the inhalation route is the quickest and most efficient way to deliver drugs to the respiratory system. This segment is also expected to grow at a substantial rate during the forecast period.

COPD and Asthma Devices Market Analysis by Indication

The Asthma segment held the dominant market share in 2021. Asthma is the most prevalent chronic illness in children and is a serious noncommunicable disease (NCD) that affects both children and adults. Adult women are more likely than adult men to have asthma in the US. Some of the factors driving the segment growth include the rising incidence of asthma in the world, as well as government and non-profit organisations' efforts to raise awareness and businesses' R&D efforts to advance asthma device technology. For instance, the first generic version of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol was approved by the US Food and Drug Administration in March 2022 for the treatment of two common pulmonary health conditions, including asthma in patients six years of age and older. Consequently, the aforementioned elements are working together to fuel the development of the segment throughout the forecast period. Asthma segment is expected to grow at a substantial CAGR during the forecast period.

To get detailed analysis on other segments, Request For Sample Report

Global COPD and Asthma Devices Market Regional Insights

North America dominated the Global COPD and Asthma Devices Market in 2021 on account of the increased prevalence of asthma and COPD together with a developed healthcare system and growing public awareness. According to the Asthma and Allergy Foundation of America (AAFA), around 1 in 13 Americans (or about 25 million individuals) had asthma in 2021, and 11 people died from the condition every day. The market is anticipated to have considerable expansion in the next years as a result of the high death rates linked to asthma and rising investment in asthma treatment in this nation. Additionally, the presence of significant market players and the development of product technologies are promoting market expansion in the area.

Asia Pacific Region is expected to witness growth at a high CAGR during the forecast period. This can be attributed to an increase in disposable income, rising healthcare costs, and growing knowledge of cutting-edge portable COPD and asthma equipment. Furthermore, the rise in active smokers and knowledge of the therapy for COPD, as well as the rising need for medication delivery systems is expected to boost the market growth of COPD and Asthma devices in this region.

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global COPD and Asthma Devices Market Dynamics

COPD and Asthma Devices Market Driver

Growing Prevalence of Different Respiratory Conditions

  • The prevalence of respiratory conditions including COPD, asthma, and emphysema is on the rise. Additionally, there is a growing need for short-term, effective treatment as well as a growing requirement for rescue medication during abrupt asthmatic attacks. Additionally, the government's measures to raise awareness of the signs of COPD and asthma, as well as manufacturers' increased focus on the development of innovative, portable inhalation devices, are anticipated to spur market expansion.
  • The Asthma and COPD Devices Market is expanding as a result of rising respiratory illness rates. Respiratory illnesses cause troubling symptoms, potentially fatal disorders, and other health issues. Chronic obstructive pulmonary disease (COPD) is brought on by lung inflammation and destruction. This causes the irritated airways to spasm and enlarge while producing too much mucus. In an attack, those with respiratory illnesses cough and have trouble breathing.
  • The market for asthma and COPD devices is expanding along with the evolution of technology. This is due to the rising prevalence of respiratory disorders and the improvements in advanced portable inhalation technologies. The most cutting-edge method of medicine delivery for respiratory ailments is through asthma and COPD devices, which may be employed as a temporary fix or a long-term cure.

COPD and Asthma Devices Market Restraint

High Cost to Hamper Market Growth

  • The market growth is anticipated to be constrained by elements like environmental issues related to metered dosage inhalers (MDI), high costs of various inhalation devices and treatments, increased price competition, and deteriorating material quality. Additionally, poor reimbursement support and the patent expiry of blockbuster medications hinder market expansion.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global COPD and Asthma Devices Market Competitive Landscape

Global COPD and Asthma Devices Market is highly competitive and fragmented due to the presence of a few prominent players. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. Major players include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co. and Philips Healthcare among others. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

COPD and Asthma Devices Market Top Player's Company Profiles

  • Smith’s Group PLC
  • GF Health Products
  • 3M Company
  • Aerogen, Inc.
  • Baxter International Inc.
  • Koninklijke Philips N.V. (Philips)
  • Novartis AG
  • PARI medical Holding GMBH
  • Omron Healthcare
  • Invacare Corporation
  • Cipla Ltd.
  • Consort Medical
  • Gerresheimer
  • NYPRO

COPD and Asthma Devices Market Recent Developments

  • In October 2022, the medical device business Acurable, located in the UK, recently revealed that Kibo Ventures, the round's lead investor, had helped the firm raise $10.8 million. The company plans to use the funding to quicken the international growth of the AcuPebble SA100, its first at-home sleep diagnostic gadget that allows users to identify and track obstructive sleep apnea. Additionally, Acurable will create fresh treatments for cardiovascular problems, asthma, and chronic obstructive pulmonary disease (COPD).
  • In March 2022, Alkem introduced the Innohaler, a DPI device, to help Asthma and COPD (Chronic Obstructive Pulmonary Disease) patients live more comfortably and to close existing gaps in Asthma care in India. Alkem is entering the core inhalation treatments with the introduction of this device and anticipating that the medication will reach the lungs effectively with each inhalation with increased patient awareness and an adherence programme.

Global COPD and Asthma Devices Key Market Trends

  • Clinical pharmacy has a lot of opportunities with digital inhalers. Inhalers have long been a go-to for those with chronic respiratory illnesses. They constitute an interesting therapeutic option since they can administer medication directly to the lungs and avoid systemic adverse effects. Medical professionals still have trouble treating COPD and asthma (COPD). Inhaler efficacy may be lowered by poor adherence and incorrect technique. Incorrect inhaler technique and non-adherence are associated with worsening dyspnea, deteriorating health, and exacerbations of existing conditions.
  • A patient's daily health may be monitored with the use of digital inhalers, which are breathing aids that can be connected to electronics. For those who have obstructive or respiratory illnesses like asthma, they are very beneficial. These inhalers have sensors that alert the user when to take their medications. Systems for monitoring inhaler actuation using digital inhalers employ microelectronics and electromechanical sensors. A cloud server, a mobile app that talks with patients, a connected smartphone, and a portal where doctors may view dashboard data are some of the devices available. Digital inhalers keep track of compliance, send Bluetooth data transmissions, and record the time, date, and position of each dose. A number of digital inhalers include sensors or offer additional sensors for standard inhalers. These devices make it easier to remember to take medicines, especially if there are numerous. They enhance the efficiency and technique of inhalation.

Global COPD and Asthma Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our Global COPD and Asthma Devices Market analysis, the growth of the market is driven by factors such as increased population susceptibility to indoor air pollutants, mobility of medication delivery devices, rise in the population of active smokers, and rise in the number of surgeries. In the near future, it is projected that increased usage of smart inhaler devices will offer a profitable growth potential for the industry. These devices are more intuitive, encourage patient engagement and adherence, and increase treatment efficacy.

Report Metric Details
Market size value in 2021 USD 38.4 billion
Market size value in 2030 USD 59.06 billion
Growth Rate 4.9%
Base year 2021
Forecast period 2023–2030
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Chronic Obstructive Pulmonary Disease (COPD) and Asthma
  • Indication
    • Retail Pharmacies, Hospitals and Online Pharmacies
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Smith’s Group PLC
  • GF Health Products
  • 3M Company
  • Aerogen, Inc.
  • Baxter International Inc.
  • Koninklijke Philips N.V. (Philips)
  • Novartis AG
  • PARI medical Holding GMBH
  • Omron Healthcare
  • Invacare Corporation
  • Cipla Ltd.
  • Consort Medical
  • Gerresheimer
  • NYPRO
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global COPD and Asthma Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global COPD and Asthma Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global COPD and Asthma Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global COPD and Asthma Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global COPD and Asthma Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global COPD and Asthma Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

COPD and Asthma Devices Market was valued at USD 38.4 billion in 2021 and 40.28 in 2022, and it is expected to reach a value of USD 59.06 billion by 2030, at a CAGR of 4.9% over the forecast period (2023–2030).

Global COPD and Asthma Devices Market is highly competitive and fragmented due to the presence of a few prominent players. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. Major players include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co. and Philips Healthcare among others. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Smith’s Group PLC', 'GF Health Products', '3M Company', 'Aerogen, Inc.', 'Baxter International Inc.', 'Koninklijke Philips N.V. (Philips)', 'Novartis AG', 'PARI medical Holding GMBH', 'Omron Healthcare', 'Invacare Corporation', 'Cipla Ltd.', 'Consort Medical', 'Gerresheimer', 'NYPRO'

Growing Prevalence of Different Respiratory Conditions

Clinical pharmacy has a lot of opportunities with digital inhalers. Inhalers have long been a go-to for those with chronic respiratory illnesses. They constitute an interesting therapeutic option since they can administer medication directly to the lungs and avoid systemic adverse effects. Medical professionals still have trouble treating COPD and asthma (COPD). Inhaler efficacy may be lowered by poor adherence and incorrect technique. Incorrect inhaler technique and non-adherence are associated with worsening dyspnea, deteriorating health, and exacerbations of existing conditions.

North America dominated the Global COPD and Asthma Devices Market in 2021 on account of the increased prevalence of asthma and COPD together with a developed healthcare system and growing public awareness. According to the Asthma and Allergy Foundation of America (AAFA), around 1 in 13 Americans (or about 25 million individuals) had asthma in 2021, and 11 people died from the condition every day. The market is anticipated to have considerable expansion in the next years as a result of the high death rates linked to asthma and rising investment in asthma treatment in this nation. Additionally, the presence of significant market players and the development of product technologies are promoting market expansion in the area.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global COPD and Asthma Devices Market

Product ID: SQMIG35B2075

$5,300
BUY NOW GET SAMPLE